LXEO
NASDAQ
$4.55
Lexeo Therapeutics Inc (LXEO)
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $20.89 (+359.12%)
Market Cap
$351M
Free Cash Flow Yield
-28.03%
Beta (5Y)
1.99
Price Chart
Valuation
Market Cap$351M
P/S478.26
P/B1.57
Profitability
Gross Profit (TTM)-$62M
EBITDA-$169M
EPS-$2.50
Financial Health
Free Cash Flow Yield-28.03%
Growth & Risk
Beta (5Y)1.99
Sharpe Ratio0.42